Table 2.
The number and mortality rate of thyroid cancer in China by sex and age, during 1990-2019, and projected until 2039.
| Case number (x 10^3) | Mortality rate (/10^5) | EAPC | ||||||
|---|---|---|---|---|---|---|---|---|
| 1990 (95%UI) | 2019 (95%UI) | 2039 (95%UI) | 1990 (95%UI) | 2019 (95%UI) | 2039 (95%UI) | 1990-2019 (95%CI) | 2020-2039 (95%CI) | |
| Both* | 3.32 (2.86,4.13) | 7.24 (6.01,8.48) | 4.16 (0.90,7.43) | 0.42 (0.37,0.53) | 0.39 (0.32,0.45) | 0.29 (0.06,0.52) | 0.06 (-0.01,0.21) | -1.34 (-1.37,-1.30) |
| Male* | 1.23 (1.00,1.52) | 4.21 (3.18,5.24) | 2.88 (0,6.92) | 0.35 (0.29,0.43) | 0.52 (0.40,0.64) | 0.39 (0.00,0.94) | 2.20 (1.86,2.54) | -1.07 (-1.11,-1.03) |
| Female* | 2.09 (1.71,2.68) | 3.03 (2.40,3.76) | 1.50 (0.48,2.50) | 0.50 (0.41,0.63) | 0.30 (0.24,0.38) | 0.21 (0.01,0.35) | -1.78 (-1.86,-1.71) | -1.82 (-1.92,-1.71) |
| Age (years)** | ||||||||
| 0 to 4 | 0 | 0 | 0.00 (0.00,0.00) | 0 | 0 | 0.00 (0.00,0.00) | 0.00 (0.00,0.00) | 0.00 (0.00,0.00) |
| 5 to 9 | 0.02 (0.02,0.03) | 0.01 (0.01,0.01) | 0.01 (0.00,0.03) | 0.02 (0.02,0.03) | 0.01 (0.01,0.02) | 0.01 (0.00,0.05) | -1.84 (-2.33,-1.35) | -2.27 (-2.28,2.27) |
| 10 to 14 | 0.03 (0.02,0.03) | 0.01 (0.01,0.01) | 0.01 (0.00,0.02) | 0.03 (0.02,0.03) | 0.02 (0.01,0.02) | 0.01 (0.00,0.04) | -2.37 (-2.90,-1.84) | -2.24 (-2.25,2.23) |
| 15 to 19 | 0.03 (0.03,0.04) | 0.01 (0.01,0.02) | 0.01 (0.00,0.02) | 0.03 (0.02,0.03) | 0.02 (0.01,0.02) | 0.01 (0.00,0.02) | -1.88 (-2.10,-1.66) | -2.23 (-2.24,-2.21) |
| 20 to 24 | 0.05 (0.04,0.07) | 0.02 (0.02,0.03) | 0.01 (0.00,0.02) | 0.04 (0.03,0.05) | 0.03 (0.02,0.04) | 0.02 (0.01,0.03) | -1.82 (-2.28,-1.37) | -2.35 (-2.42,-2.29) |
| 25 to 29 | 0.07 (0.05,0.08) | 0.05 (0.04,0.06) | 0.02 (0.01,0.03) | 0.06 (0.05,0.08) | 0.04 (0.04,0.05) | 0.02 (0.02,0.03) | -1.68 (-2.26,-1.10) | -2.71 (-2.83,-2.59) |
| 30 to 34 | 0.08 (0.06,0.10) | 0.08 (0.06,0.09) | 0.03 (0.02,0.04) | 0.09 (0.07,0.11) | 0.06 (0.05,0.07) | 0.03 (0.03,0.05) | -2.32 (-2.91,-1.71) | -3.06 (-3.15,-2.97) |
| 35 to 39 | 0.13 (0.10,0.16) | 0.09 (0.08,0.11) | 0.04 (0.03,0.06) | 0.14 (0.11,0.17) | 0.09 (0.08,0.11) | 0.05 (0.04,0.06) | -1.94 (-2.16,-1.72) | -2.99 (-3.11,-2.87) |
| 40 to 44 | 0.17 (0.14,0.21) | 0.18 (0.14,0.22) | 0.08 (0.06,0.11) | 0.25 (0.20,0.31) | 0.18 (0.14,0.21) | 0.10 (0.08,0.12) | -1.40 (-1.55,-1.25) | -2.47 (-2.66,-2.28) |
| 45 to 49 | 0.16 (0.13,0.20) | 0.3 (0.23,0.37) | 0.16 (0.12,0.20) | 0.32 (0.26,0.38) | 0.25 (0.20,0.31) | 0.15 (0.12,0.19) | -0.59 (-0.90,-0.27) | -1.94 (-2.05,-1.84) |
| 50 to 54 | 0.28 (0.23,0.34) | 0.57 (0.44,0.70) | 0.36 (0.27,0.44) | 0.58 (0.48,0.71) | 0.45 (0.35,0.56) | 0.29 (0.23,0.35) | -0.62 (-0.75,-0.48) | -2.11 (-2.29,-1.92) |
| 55 to 59 | 0.39 (0.32,0.48) | 0.7 (0.56,0.86) | 0.45 (0.35,0.55) | 0.90 (0.75,1.10) | 0.74 (0.59,0.91) | 0.49 (0.40,0.59) | -0.13 (-0.39,0.13) | -2.60 (-2.82,-2.38) |
| 60 to 64 | 0.35 (0.29,0.46) | 0.59 (0.49,0.71) | 0.51 (0.40,0.62) | 0.99 (0.83,1.30) | 0.75 (0.62,0.90) | 0.54 (0.44,0.66) | -0.69 (-0.85,-0.52) | -2.02 (-2.46,-1.59) |
| 65 to 69 | 0.38 (0.32,0.51) | 0.79 (0.66,0.94) | 0.98 (0.77,1.18) | 1.38 (1.16,1.88) | 1.12 (0.94,1.34) | 0.89 (0.73,1.10) | -0.43 (-0.62,-0.24) | -1.19 (-1.56,-0.82) |
| 70 to 74 | 0.37 (0.31,0.53) | 0.81 (0.69,0.96) | 1.62 (1.29,1.95) | 1.94 (1.63,2.81) | 1.7 (1.44,2.01) | 1.67 (1.37,2.04) | -0.26 (-0.47,-0.05) | -0.73 (-0.93,-0.52) |
| 75 to 79 | 0.39 (0.34,0.55) | 1.22 (0.97,1.46) | 2.38 (1.90,2.86) | 3.45 (2.97,4.79) | 4.1 (3.26,4.88) | 3.77 (3.09,4.59) | 1.43 (1.08,1.77) | -1.10 (-1.21,-0.98) |
| 80+ | 0.42 (0.36,0.52) | 1.8 (1.46,2.07) | 4.00 (3.20,4.79) | 5.20 (4.54,6.53) | 5.95 (4.82,6.85) | 5.70 (4.67,6.94) | 0.91 (0.66,1.16) | -0.94 (-1.05,-0.84) |
EAPC, estimated annual percentage change; 95% UI, 95% uncertainty interval; 95% CI, 95% confidence interval; *, age-standardized of mortality rate; **, crude mortality rate in each age group.